Latest Breaking News On - Claire beveridge - Page 2 : vimarsana.com

Eosinophilic Esophagitis: Experts Address Your Burning Questions

healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkChapel hillRecludix pharmaIkuo hiranoEvans dellonAdare ellodiEllodi adareSanofi regeneronBristol myers squibb celgeneMirna chehadeClaire beveridgeRonalda codarioRobarts alimentivRegeneron pharmaceuticals incMount sinai center

Ace the Case: A 34-Year-Old Woman With Painful Swallowing

Ace the Case: A 34-Year-Old Woman With Painful Swallowing
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesRonalda codarioBarbaraa niedzClaire beveridgeChiara maruggiCase western reserve universityCleveland clinic lerner college of medicineOffice of medical affairsAmerican nurses credentialing centerAccreditation council for continuing medical educationDepartment of gastroenterologyAccreditation council for pharmacy educationClinic lerner collegeVindico medical educationAccreditation councilContinuing medical education

Ace the Case: A 48-Year-Old Woman With Diarrhea and Bloating

Ace the Case: A 48-Year-Old Woman With Diarrhea and Bloating
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesLady katherine mejia perezRonalda codarioClaire beveridgeBarbaraa niedzCase western reserve universityOffice of medical affairsCleveland clinic lerner college of medicineAmerican nurses credentialing centerAccreditation council for pharmacy educationDepartment of gastroenterologyAccreditation council for continuing medical educationClinic lerner collegeKatherine mejia perezVindico medical educationAccreditation council

FDA approves first treatment for eosinophilic esophagitis in the US

The FDA has granted approval for dupilumab for the treatment of eosinophilic esophagitis for adult and pediatric patients aged 12 years and older, according to a press release. Dupilumab (Dupixent, Sanofi; Regeneron Pharmaceuticals, Inc.) is the first drug in the U.S. specifically indicated for the treatment of this condition.

Claire beveridgeDupilumab dupixentEvan dellonUniversity of north carolina school medicineRegeneron pharmaceuticals incRegeneron pharmaceuticalsNorth carolina schoolDysphagia symptom questionnaire